Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: axial who wrote (10493)	8/9/2002 1:04:16 PM
From: Joe Krupa	Read Replies (2) \| Respond to of 14101

Hi Jim, "The problem is both financial and tactical. $1.5 billion US is not chump change - and some might consider that price low. There's the prospect of significant competitive pressure. One or many partners? Would the chances of success be increased by having multiple partners, one for each targeted therapeutic area?" It is mind boggling to me what people are missing here. Yes, the PIII results are pivotal here, but if they do ONCE AGAIN confirm the BMA hypothesis, then one of the world's biggest ever drugs may be born! And there is every reason to believe that the PIII results will successfully confirm the BMA, and replicate Vanderbilt People who laugh at my assertion here, will not have researched WF10 enough. It may be hard to find scientific information on WF10, but it is out there for the diligent investigator. What Dr.Kuhne, McGrath and associates have created is nothing short of staggering in terms of both its clinical applications and market potential. There is more potential in one small clinical indication of WF10 than there is in everything QLT, as a company, has in total. I'm sorry, I like ONC, ISA and BRA, but I don't believe any of them has anything close to the potential of WF10. Add all this potential to the fact that phase III's for WF10 are wrapped up, and likely a candidate for fast track approval. IMO, many many years from now, Dr. Kuhne and Dr. McGrath will enjoy a similar legend and lore to Banting and Best. I had to get this out. joe